Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor
NCT01212341
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Malignant Lymphomas
Solid Tumors
Interventions
BIOLOGICAL:
Allogeneic NK cells
Sponsor
Seoul National University Hospital
Collaborators
[object Object]